Literature DB >> 32162672

Association Between Methylenetetrahydrofolate Reductase Gene Polymorphisms and Risk of Vitiligo: A Systematic Review and Meta-Analysis.

Hua-Ching Chang1, Ming-Hsiu Lin, Hsiou-Hsin Tsai.   

Abstract

Entities:  

Keywords:  meta-analysis; methylenetetrahydrofolate reductase; systematic review; vitiligo; gene polymorphisms

Mesh：

Substances：

Year:  2020        PMID： 32162672      PMCID： PMC9128875          DOI： 10.2340/00015555-3448

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  11 in total

Review 1.  Therapeutic management of vitiligo.

Authors:  Rachela Bleuel; Bernadette Eberlein
Journal:  J Dtsch Dermatol Ges       Date:  2018-10-18       Impact factor: 5.584

2.  Estimation of Homocysteine Level and Methylenetetrahydrofolate Reductase (MTHFR) Gene and Cystathionine B Synthase (CBS) Gene Polymorphisms in Vitiligo Patients.

Authors:  Samar El Tahlawi; Dalia M Abdel Halim; Heba El Hadidi; Marwa M Fawzy; Rehab A Hegazy; Marwa Ezzat; Sherin M Elgohary; Olfat Shaker; Khadiga S Sayed
Journal:  Skin Pharmacol Physiol       Date:  2019-11-28       Impact factor: 3.479

3.  Association of elevated homocysteine levels and Methylenetetrahydrofolate reductase (MTHFR) 1298 A > C polymorphism with Vitiligo susceptibility in Gujarat.

Authors:  Shahnawaz D Jadeja; Mohmmad Shoab Mansuri; Mala Singh; Hima Patel; Yogesh S Marfatia; Rasheedunnisa Begum
Journal:  J Dermatol Sci       Date:  2018-01-31       Impact factor: 4.563

Review 4.  Pharmacogenetic relevance of MTHFR polymorphisms.

Authors:  Giuseppe Toffoli; Elena De Mattia
Journal:  Pharmacogenomics       Date:  2008-09       Impact factor: 2.533

5.  Genetic polymorphisms in the methylenetetrahydrofolate reductase gene (MTHFR) and risk of vitiligo in Han Chinese populations: a genotype-phenotype correlation study.

Authors:  J-X Chen; Q Shi; X-W Wang; S Guo; W Dai; K Li; P Song; C Wei; G Wang; C-Y Li; T-W Gao
Journal:  Br J Dermatol       Date:  2014-05       Impact factor: 9.302

6.  Serum homocysteine, folate, and vitamin B12 levels in patients with vitiligo and their potential roles as disease activity biomarkers: A systematic review and meta-analysis.

Authors:  Tsung-Yu Tsai; Che-Yuan Kuo; Yu-Chen Huang
Journal:  J Am Acad Dermatol       Date:  2018-08-28       Impact factor: 11.527

Review 7.  Meta-analysis of genetic association studies.

Authors:  Young Ho Lee
Journal:  Ann Lab Med       Date:  2015-04-01       Impact factor: 3.464

Review 8.  Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci.

Authors:  Changbing Shen; Jing Gao; Yujun Sheng; Jinfa Dou; Fusheng Zhou; Xiaodong Zheng; Randy Ko; Xianfa Tang; Caihong Zhu; Xianyong Yin; Liangdan Sun; Yong Cui; Xuejun Zhang
Journal:  Front Genet       Date:  2016-02-01       Impact factor: 4.599

9.  Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants.

Authors:  Ying Jin; Genevieve Andersen; Daniel Yorgov; Tracey M Ferrara; Songtao Ben; Kelly M Brownson; Paulene J Holland; Stanca A Birlea; Janet Siebert; Anke Hartmann; Anne Lienert; Nanja van Geel; Jo Lambert; Rosalie M Luiten; Albert Wolkerstorfer; J P Wietze van der Veen; Dorothy C Bennett; Alain Taïeb; Khaled Ezzedine; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Sulev Kõks; Ele Prans; Külli Kingo; Maire Karelson; Margaret R Wallace; Wayne T McCormack; Andreas Overbeck; Silvia Moretti; Roberta Colucci; Mauro Picardo; Nanette B Silverberg; Mats Olsson; Yan Valle; Igor Korobko; Markus Böhm; Henry W Lim; Iltefat Hamzavi; Li Zhou; Qing-Sheng Mi; Pamela R Fain; Stephanie A Santorico; Richard A Spritz
Journal:  Nat Genet       Date:  2016-10-10       Impact factor: 38.330

10.  Serum homocysteine, vitamin B12, folic acid levels and methylenetetrahydrofolate reductase (MTHFR) gene polymorphism in vitiligo.

Authors:  Ali Yasar; Kamer Gunduz; Ece Onur; Mehmet Calkan
Journal:  Dis Markers       Date:  2012       Impact factor: 3.434
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.